Moderna stock popped 9% on Friday after the New York Times reported new details about an effort to speed up cancer vaccine ...

<?xml encoding="utf-8" ?> A nationwide initiative to accelerate personalized cancer vaccine development is drawing fresh ...

New details have emerged about an initiative that starts in December to fast-track the vaccines, similar to the successful ...

Moderna stock gains on reports of an initiative to accelerate cancer vaccine development. Here’s why caution is warranted in ...

Moderna stock popped 9% on Friday after the New York Times reported new details about an effort to speed up cancer vaccine development. Investors saw the mRNA biotech company, in particular, as a ...

Add Yahoo as a preferred source to see more of our stories on Google. Moderna is developing an mRNA vaccine for the Bundibugyo virus driving the Ebola outbreak in the Democratic Republic of the Congo.

In the early 2000s, immunologist Bali Pulendran started his lab at Emory University to explore the mechanisms underlying vaccine-mediated immunity. To uncover these processes, he focused on the yellow ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

It's recommended that all adolescents get vaccinated against human papillomavirus (HPV), as the infection can cause cancer.

The US Department of Health and Human Services launched a program this week to study and capture the breadth of vaccine ...

Lakshmi Srinivasan, PhD, former Executive Director and Head of Oncology Translational Medicine at Moderna, and Brandon Coder, ...